Help | RSS Feed



Aevi Genomic Medicine, Inc. (NASD:GNMX) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Aevi Genomic Medicine, Inc. (NASD:GNMX) seasonal charts above shows that a Buy Date of December 11 and a Sell Date of March 10 has resulted in a geometric average return of 15.34% above the benchmark rate of the S&P 500 Total Return Index over the past 7 years. This seasonal timeframe has shown positive results compared to the benchmark in 5 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 7 years by an average of 41.13% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 7 years of data is available for shares of GNMX, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Aevi Genomic Medicine Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore